Literature DB >> 15920485

Expression of BEX1 in acute myeloid leukemia with MLL rearrangements.

H Quentmeier, R Tonelli, R Geffers, A Pession, C C Uphoff, H G Drexler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15920485     DOI： 10.1038/sj.leu.2403820

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia.

Authors:  Riccardo Masetti; Marco Togni; Annalisa Astolfi; Martina Pigazzi; Elena Manara; Valentina Indio; Carmelo Rizzari; Sergio Rutella; Giuseppe Basso; Andrea Pession; Franco Locatelli
Journal:  Oncotarget       Date:  2013-10

2.  Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.

Authors:  Kyung-Nam Koh; Jin Ok Lee; Eul Ju Seo; Seong Wook Lee; Jin Kyung Suh; Ho Joon Im; Jong Jin Seo
Journal:  J Korean Med Sci       Date:  2014-07-11       Impact factor: 2.153

3.  Brain expressed and X-linked (Bex) proteins are intrinsically disordered proteins (IDPs) and form new signaling hubs.

Authors:  Eva M Fernandez; María D Díaz-Ceso; Marçal Vilar
Journal:  PLoS One       Date:  2015-01-22       Impact factor: 3.240

4.  BEX1 acts as a tumor suppressor in acute myeloid leukemia.

Authors:  Oscar Lindblad; Tianfeng Li; Xianwei Su; Jianmin Sun; Nuzhat N Kabir; Fredrik Levander; Hui Zhao; Gang Lu; Lars Rönnstrand; Julhash U Kazi
Journal:  Oncotarget       Date:  2015-08-28

5.  Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia.

Authors:  Sonja Röhrs; Wilhelm G Dirks; Claus Meyer; Rolf Marschalek; Michaela Scherr; Robert Slany; Andrew Wallace; Hans G Drexler; Hilmar Quentmeier
Journal:  Mol Cancer       Date:  2009-10-16       Impact factor: 27.401

6.  Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells.

Authors:  E Camilla Forsberg; Emmanuelle Passegué; Susan S Prohaska; Amy J Wagers; Martina Koeva; Joshua M Stuart; Irving L Weissman
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

7.  Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity.

Authors:  Ian J Majewski; Marnie E Blewitt; Carolyn A de Graaf; Edward J McManus; Melanie Bahlo; Adrienne A Hilton; Craig D Hyland; Gordon K Smyth; Jason E Corbin; Donald Metcalf; Warren S Alexander; Douglas J Hilton
Journal:  PLoS Biol       Date:  2008-04-15       Impact factor: 8.029

8.  Genome-wide methylation profiling demonstrates hypermethylation in maternal leukocyte DNA in preeclamptic compared to normotensive pregnancies.

Authors:  Wendy M White; Brian Brost; Zhifu Sun; Carl Rose; Iasmina Craici; Steven J Wagner; Stephen T Turner; Vesna D Garovic
Journal:  Hypertens Pregnancy       Date:  2013-06-19       Impact factor: 2.108

9.  BEX1 is an RNA-dependent mediator of cardiomyopathy.

Authors:  Federica Accornero; Tobias G Schips; Jennifer M Petrosino; Shan-Qing Gu; Onur Kanisicak; Jop H van Berlo; Jeffery D Molkentin
Journal:  Nat Commun       Date:  2017-11-30       Impact factor: 14.919
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.